Healthcare provider profile · identity verified

Allison Wilkin

Internal Medicine · BIRMINGHAM, AL · NPI 1396003661

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	664	211
Amlodipine Besylate	Amlodipine Besylate	416	143
Levothyroxine Sodium	Levothyroxine Sodium	254	73
Losartan Potassium	Losartan Potassium	228	73
Gabapentin	Gabapentin	212	72
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	209	32
Pravastatin Sodium	Pravastatin Sodium	209	59
Pantoprazole Sodium	Pantoprazole Sodium	195	67
Hydrochlorothiazide	Hydrochlorothiazide	177	62
Omeprazole	Omeprazole	177	56
Rosuvastatin Calcium	Rosuvastatin Calcium	163	51
Lisinopril	Lisinopril	160	50
Metoprolol Succinate	Metoprolol Succinate	158	52
Tramadol Hcl	Tramadol Hcl	154	34
Metformin Hcl	Metformin Hcl	136	49
Carvedilol	Carvedilol	135	51
Eliquis	Apixaban	135	34
Ozempic	Semaglutide	131	18
Trazodone Hcl	Trazodone Hcl	121	37
Zolpidem Tartrate	Zolpidem Tartrate	113	27
Escitalopram Oxalate	Escitalopram Oxalate	111	37
Furosemide	Furosemide	100	44
Metformin Hcl Er	Metformin Hcl	100	36
Sertraline Hcl	Sertraline Hcl	93	31
Fluticasone Propionate	Fluticasone Propionate	92	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	89	31
Meloxicam	Meloxicam	88	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	87	28
Albuterol Sulfate Hfa	Albuterol Sulfate	84	36
Fluoxetine Hcl	Fluoxetine Hcl	84	24
Clonazepam	Clonazepam	82	22
Montelukast Sodium	Montelukast Sodium	82	29
Simvastatin	Simvastatin	81	30
Chlorthalidone	Chlorthalidone	78	23
Spironolactone	Spironolactone	70	23
Famotidine	Famotidine	68	22
Pregabalin	Pregabalin	67	17
Potassium Chloride	Potassium Chloride	60	27
Alprazolam	Alprazolam	59	19
Esomeprazole Magnesium	Esomeprazole Magnesium	57	19
Olmesartan Medoxomil	Olmesartan Medoxomil	57	17
Methocarbamol	Methocarbamol	56	19
Allopurinol	Allopurinol	55	23
Duloxetine Hcl	Duloxetine Hcl	54	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	16
Jardiance	Empagliflozin	53	15
Mounjaro	Tirzepatide	52	12
Bupropion Xl	Bupropion Hcl	51	15
Hydralazine Hcl	Hydralazine Hcl	49	13
Estradiol	Estradiol	48	21
Metoprolol Tartrate	Metoprolol Tartrate	48	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	suppressed
Januvia	Sitagliptin Phosphate	47	suppressed
Atenolol	Atenolol	46	15
Clopidogrel	Clopidogrel Bisulfate	44	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	12
Lorazepam	Lorazepam	42	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	15
Alendronate Sodium	Alendronate Sodium	40	18
Baclofen	Baclofen	40	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	12
Tamsulosin Hcl	Tamsulosin Hcl	35	14
Citalopram Hbr	Citalopram Hydrobromide	34	15
Amitriptyline Hcl	Amitriptyline Hcl	33	13
Ezetimibe	Ezetimibe	33	11
Tizanidine Hcl	Tizanidine Hcl	33	16
Valsartan	Valsartan	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Celecoxib	Celecoxib	27	11
Diclofenac Sodium	Diclofenac Sodium	27	12
Azelastine Hcl	Azelastine Hcl	26	13
Irbesartan	Irbesartan	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Felodipine Er	Felodipine	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Finasteride	Finasteride	23	suppressed
Glipizide	Glipizide	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Trulicity	Dulaglutide	23	suppressed
Ondansetron Odt	Ondansetron	22	12
Xarelto	Rivaroxaban	22	suppressed
Lidocaine	Lidocaine	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Prednisone	Prednisone	17	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Ramipril	Ramipril	16	suppressed
Diazepam	Diazepam	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Temazepam	Temazepam	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	14
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Fluconazole	Fluconazole	13	11
Naproxen	Naproxen	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Colchicine	Colchicine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error